LU79005A1 - Procede de preparation de nouveaux derives 4"-amines d'oleandomycine et de medicaments les contenant - Google Patents

Procede de preparation de nouveaux derives 4"-amines d'oleandomycine et de medicaments les contenant

Info

Publication number
LU79005A1
LU79005A1 LU79005A LU79005A LU79005A1 LU 79005 A1 LU79005 A1 LU 79005A1 LU 79005 A LU79005 A LU 79005A LU 79005 A LU79005 A LU 79005A LU 79005 A1 LU79005 A1 LU 79005A1
Authority
LU
Luxembourg
Prior art keywords
oleandomycin
preparation
new
amine derivatives
medicines containing
Prior art date
Application number
LU79005A
Other languages
English (en)
French (fr)
Inventor
R Myers
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of LU79005A1 publication Critical patent/LU79005A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
LU79005A 1977-02-04 1978-02-03 Procede de preparation de nouveaux derives 4"-amines d'oleandomycine et de medicaments les contenant LU79005A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/765,488 US4085119A (en) 1977-02-04 1977-02-04 4-Substituted amino derivatives of oleandomycin

Publications (1)

Publication Number Publication Date
LU79005A1 true LU79005A1 (fr) 1979-09-06

Family

ID=25073690

Family Applications (1)

Application Number Title Priority Date Filing Date
LU79005A LU79005A1 (fr) 1977-02-04 1978-02-03 Procede de preparation de nouveaux derives 4"-amines d'oleandomycine et de medicaments les contenant

Country Status (11)

Country Link
US (2) US4085119A (xx)
JP (1) JPS5398983A (xx)
BE (1) BE863620A (xx)
DE (1) DE2804517C3 (xx)
DK (1) DK148035C (xx)
FR (1) FR2379551A1 (xx)
GB (1) GB1593644A (xx)
IE (1) IE46394B1 (xx)
IT (1) IT1094210B (xx)
LU (1) LU79005A1 (xx)
NL (1) NL171588C (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4189590A (en) * 1976-08-06 1980-02-19 Pfizer Inc. Semi-synthetic oleandomycin derivatives--C8 modifications
US4180654A (en) * 1978-01-03 1979-12-25 Pfizer Inc. 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate
US4133950A (en) * 1978-01-03 1979-01-09 Pfizer Inc. 4"-Deoxy-4"-carbamate and dithiocarbamate derivatives of oleandomycin and its esters
US4166901A (en) * 1978-01-03 1979-09-04 Pfizer Inc. 4"-Deoxy-4"-arylglyoxamido- and aroylthioformamido derivatives of oleandomycin and its esters
US4124755A (en) * 1978-01-03 1978-11-07 Pfizer Inc. 11-Alkanoyl-4"-deoxy-4"-isonitrilo-oleandomycin derivatives
US4316010A (en) * 1981-01-02 1982-02-16 Pfizer Inc. Cis-C3 "C4 "-carbonate derivatives of O-demethyloleandomycin and intermediates therefor
IT1169013B (it) 1981-01-09 1987-05-20 Pierrel Spa Composti macrolidici ad attivita' antibiotica, procedimento e microorganismo per la loro preparazione e relative composizioni farmaceutiche
US4336368A (en) * 1981-04-20 1982-06-22 Pfizer Inc. 4 Deoxy-4-methylene oleandomycin and derivatives thereof
US4427663A (en) 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
US4808590A (en) * 1987-07-17 1989-02-28 Harbor Branch Oceanographic Institution, Inc. Antiviral, antitumor and antifungal compositions and their methods of use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2870138A (en) * 1953-08-13 1959-01-20 Upjohn Co Erythromycin salts
US3357999A (en) * 1965-12-23 1967-12-12 Abbott Lab Anhydrotriacetylerythronolide b
US3842068A (en) * 1972-06-15 1974-10-15 Abbott Lab 8-epi-erythromycins
US3836519A (en) * 1973-05-04 1974-09-17 Abbott Lab Sulfonyl derivatives of erythromycin
US3928387A (en) * 1974-02-04 1975-12-23 Hoffmann La Roche Antibiotic 1745A/X and methods for the production thereof
US3963696A (en) * 1975-02-21 1976-06-15 Abbott Laboratories 6,6A-AND 6,7-Anhydroerythromycin B and derivatives thereof
US4036853A (en) * 1976-08-06 1977-07-19 Pfizer Inc. Semi-synthetic oleandomycin derivatives-C8 modifications

Also Published As

Publication number Publication date
US4085119A (en) 1978-04-18
JPS5398983A (en) 1978-08-29
IT1094210B (it) 1985-07-26
DE2804517B2 (de) 1980-09-25
DE2804517A1 (de) 1978-08-10
DK51678A (da) 1978-08-05
JPS5628918B2 (xx) 1981-07-04
DK148035B (da) 1985-02-11
NL171588C (nl) 1983-04-18
BE863620A (fr) 1978-08-03
GB1593644A (en) 1981-07-22
FR2379551B1 (xx) 1980-08-29
NL171588B (nl) 1982-11-16
IE46394B1 (en) 1983-06-01
DK148035C (da) 1985-07-15
IT7820007A0 (it) 1978-02-03
US4140848A (en) 1979-02-20
FR2379551A1 (fr) 1978-09-01
IE780234L (en) 1978-08-04
NL7801261A (nl) 1978-08-08
DE2804517C3 (de) 1981-05-07

Similar Documents

Publication Publication Date Title
BE838924A (fr) Nouveaux esters alkyliques d'acides 1,4-dihydropyridine-carboxyliques, leur procede de preparation et medicament les contenant
BE869793A (fr) Nouveaux derives d'amines et amidines de glycerols et propanediols et medicaments les contenant
LU78330A1 (fr) Procede de preparation de nouveaux derives d'hydantoine et de composition pharmaceutique les contenant
FR2306703A1 (fr) Nouveaux derives d'erythromycine, procede pour leur preparation et medicaments les renfermant
FR2297037A1 (fr) Nouveaux derives de biphenyloxy, medicaments les contenant et procede pour leur preparation
FR2344531A1 (fr) Nouveaux derives de l'acide sulfonamidobenzoique, leur procede de preparation et medicaments les contenant
BE871770A (fr) Nouveaux derives de phtalazine, leur procede de production et composition pharmaceutique les contenant
LU79005A1 (fr) Procede de preparation de nouveaux derives 4"-amines d'oleandomycine et de medicaments les contenant
LU79006A1 (fr) Procede de preparation de 4"-deoxy-4"-(amino substitue)-oleandomycines et de medicaments les contenant
BE876297A (fr) Nouveaux derives de 4-amino-2-piperidino-quinazoline, leur procede de production et medicament les contenant
BE838213A (fr) Nouveaux ethers d'oximes, procede de preparation de ceux-ci et medicaments les contenant
LU80747A1 (fr) Nouveaux derives 4"-deoxy-4"-acylamido de l'oleandomycine,de l'erythromycine et du carbonate d'erythromycine,leur procede de production et composition pharmaceutique les contenant
BE865601A (fr) Medicaments contenant des alcenylxanthines et leur procede de preparation
FR2333496A2 (fr) Nouveaux derives d'ethanolamine, leur procede de preparation et composition pharmaceutique les contenant
PT74651A (fr) Procede de preparation de derives de pyridine et de compositions pharmaceutiques les contenant
PT82364A (fr) Procede de preparation de derives du nitrofuranne et de compositions pharmaceutiques les contenant
BE884620A (fr) Nouveaux derives d'halovincamone, leur procede de preparation et medicaments les contenant
FR2292477A1 (fr) Derives de 1-amidoalkyl-4-sulfonyl-piperazine, leur procede d'obtention et medicaments contenant lesdits derives
BE837698A (fr) Nouveaux derives de 4-aminoquinoleine, leur procede de preparation et composition pharmaceutique les contenant
LU79004A1 (fr) Procede de preparation de nouveaux derives semi-synthetiques de 4"-erythromycine a et de medicaments les contenant
BE858781A (fr) Nouveaux derives 1,4-dihydropyridiques de sucres, leur procede de preparation et medicament les contenant
FR2290211A1 (fr) Nouveaux 1,1-bioxydes de 4-hydroxy-2h-naphto (2,1-e)-1,2-thiazine-3-carboxamides, leur procede de preparation et medicaments les renfermant
BE878836A (fr) Derives d'acide hydroxamique, leur procede de preparation et medicament les contenant
BE884171A (fr) Nouveaux derives de l'ergol-8-ene et de l'ergoline, procede de preparation de ces derives et medicaments les contenant
FR2586681B1 (fr) Derives du methylene-dioxy-phenanthrene et du stilbene, procede pour leur preparation et medicaments les contenant